Home › Compare › IPDQF vs ORCC

IPDQF vs ORCC: Dividend Comparison 2026

IPDQF yields 15037.59% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPDQF wins by $3104511204105704960.00M in total portfolio value
10 years
IPDQF
IPDQF
● Live price
15037.59%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3104511204105704960.00M
Annual income
$3,064,423,771,321,618,000,000,000.00
Full IPDQF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — IPDQF vs ORCC

📍 IPDQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPDQFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPDQF + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IPDQF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPDQF
Annual income on $10K today (after 15% tax)
$1,278,195.49/yr
After 10yr DRIP, annual income (after tax)
$2,604,760,205,623,375,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, IPDQF beats the other by $2,604,760,205,623,375,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPDQF + ORCC for your $10,000?

IPDQF: 50%ORCC: 50%
100% ORCC50/50100% IPDQF
Portfolio after 10yr
$1552255602052852480.00M
Annual income
$1,532,211,885,660,809,000,000,000.00/yr
Blended yield
98.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

IPDQF
No analyst data
Altman Z
-15.0
Piotroski
3/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPDQF buys
0
ORCC buys
0
No recent congressional trades found for IPDQF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPDQFORCC
Forward yield15037.59% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$3104511204105704960.00M ✓$21.4K
Annual income after 10y$3,064,423,771,321,618,000,000,000.00 ✓$1.04
Total dividends collected$3101858743028932096.00M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: IPDQF vs ORCC ($10,000, DRIP)

YearIPDQF PortfolioIPDQF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$1,514,459$1,503,759.40$11,190$489.61+$1.50M → IPDQF
2$214,459,963$212,839,491.04$12,229$256.01+$214.45M → IPDQF
3$28,397,537,874$28,168,065,713.66$13,216$130.74+$28397.52M → IPDQF
4$3,516,227,452,018$3,485,842,086,493.21$14,207$66.02+$3516227.44M → IPDQF
5$407,147,790,082,622$403,385,426,708,962.75$15,234$33.17+$407147790.07M → IPDQF
6$44,088,392,095,723,320$43,652,743,960,334,910.00$16,317$16.62+$44088392095.71M → IPDQF
7$4,464,912,509,400,862,700$4,417,737,929,858,439,000.00$17,468$8.32+$4464912509400.85M → IPDQF
8$422,901,232,740,949,000,000$418,123,776,355,890,040,000.00$18,695$4.16+$422901232740948.94M → IPDQF
9$37,464,890,452,417,863,000,000$37,012,386,133,385,048,000,000.00$20,006$2.08+$37464890452417864.00M → IPDQF
10$3,104,511,204,105,705,000,000,000$3,064,423,771,321,618,000,000,000.00$21,407$1.04+$3104511204105704960.00M → IPDQF

IPDQF vs ORCC: Complete Analysis 2026

IPDQF — Stock

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Full IPDQF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this IPDQF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPDQF vs SCHDIPDQF vs JEPIIPDQF vs OIPDQF vs KOIPDQF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.